Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Describe Vascular and Renal Effects and Safety of Valsartan 80 and 160 mg in Arterial Hypertension Patients

NCT00171353 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00171353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00171353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Describe Vascular and Renal Effects and Safety of Valsartan 80 and 160 mg in Arterial Hypertension Patients
Lead sponsor
Novartis
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2004
Completion date
September 30, 2005
Enrollment
109 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension